Insider Cluster (3 insiders) ·Filed Apr 27, 2026

WST

WEST PHARMACEUTICAL SERVICES INC
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $1.1M total
Actionable Insight • Neutral

The insider sales are too small to signal concern. Monitor for any increase in selling volume or pattern changes. The recent strong earnings support a neutral view on fundamentals.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
WST ▲ +19.10% at T+60d
NEUTRAL call ✓ call won +19.10% · α vs SPY +14.59% · entry $300.93 → $358.41
Entry anchored
Apr 24, 03:59 PM ET
via exchange tick
T+1d
-3.04%
call -3.04% · α -2.56%
$291.78
settled 5mo ago
T+5d
-0.42%
call -0.42% · α -0.82%
$299.68
settled 5mo ago
T+20d
+5.06%
call +5.06% · α +0.11%
$316.17
settled 4mo ago
T+60d
+19.10%
call +19.10% · α +14.59%
$358.41
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Two insiders sold $1.13M worth of WST shares (0.005% of market cap) following strong Q1 earnings. The sales are immaterial relative to the company's $21.9B market cap and likely represent routine profit-taking post-earnings.

Key Financial Metrics

Direction
selling
Total Value
$1.1M
Insiders
3

Key Facts

  • Sr. VP & Chief HR Officer Annette F Favorite sold 2,800 shares at ~$305.20 for $860K.
  • VP & Chief Accounting Officer Chad Winters sold 896 shares at ~$300.67 for $269K.
  • Director Mark A Buthman received a grant of 791 shares at $0 (non-cash).
  • Total sales represent about 0.005% of WST's $21.9B market cap.
  • Insider activity follows a strong Q1 earnings report released April 23, 2026.

Financial Impact

Total insider sales of $1.13M, negligible relative to market cap.

insider holdings

Risk Factors

  • Insider selling could accelerate if more insiders follow, but current activity is routine.
  • Stock may have limited upside after recent rally if earnings optimism is already priced in.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
83% bullish (23 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-WST-1778102334094
12 reports for WST
Performance horizon
50% Hit rate 2 of 4 directional calls best @ T+60▲ +16.33%Apr 23, 2026
Filters
Rows
Reports for WST — sortable, filterable
TypeNow
Jul 23, 2026
10w ago
8-K
BULLISH ★ 7/10
$355.48 $353.77▼ −0.48%▼ −3.79%$364.89 (+2.65%)
Jul 23, 2026
10w ago
Press Release
BULLISH ★ 7/10
$355.48 $353.77▼ −0.48%▼ −3.79%$364.89 (+2.65%)
Jul 7, 2026
12w ago
Press Release
NEUTRAL ★ 1/10
$356.08 $347.94▼ −2.29%▼ −3.62%$364.89 (+2.47%)
May 11, 2026
20w ago
8-K
BEARISH ★ 7/10
$311.82 $330.92▼ −6.12%▼ −7.85%$364.89 (−17.02%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Apr 27, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $316.17▲ +5.06%▲ +0.11%$364.89 (+21.25%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (65h 29m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 6, 2026